| Catalogue number: | PA 27 0033113 |
| Chemical name: | 2,2',2''-(10-(2-((2-(((((1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-yl)methoxy)carbonyl)amino)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid |
CAS Number: |
2565792-45-0 |
| Category: | miscellaneous compounds,Antibody Drug Conjugate |
| Synonyms: | 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[[2-[[[(1α,8α,9β)-bicyclo[6.1.0]non-4-yn-9-ylmethoxy]carbonyl]amino]ethyl]amino]-2-oxoethyl]-; 10-[2-[[2-[[[(1α,8α,9β)-Bicyclo[6.1.0]non-4-yn-9-ylmethoxy]carbonyl]amino]ethyl]amino]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic Acid; BCN-DOTA; |
| Molecular form: | C29H46N6O9 |
| Appearance: | NA |
| Mol. Weight: | 622.72 |
| Storage: | 2-8°C Refrigerator |
| Shipping Conditions: | Ambient |
| Applications: | BCN-DOTA is a cyclooctyne-linked DOTA chelator that can be radiolabeled with zirconium-89 as a radionuclide-labeled drug conjugate (RDC) to target specific biomolecules, cells, or tissues |
2,2',2''-(10-(2-((2-(((((1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-yl)methoxy)carbonyl)amino)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid
2,2',2''-(10-(2-((2-(((((1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-yl)methoxy)carbonyl)amino)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid
Enquire for 2,2',2''-(10-(2-((2-(((((1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-yl)methoxy)carbonyl)amino)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid
Order Product
Related Products
EVENTS
Search by Keywords – Buy 2565792-45-0 | Purchase 2565792-45-0 | Order 2565792-45-0 | Enquire 2565792-45-0 | Price of 2565792-45-0 | 2565792-45-0 Cost | 2565792-45-0 Supplier | 2565792-45-0 Distributor | 2565792-45-0 Manufacturer | 2565792-45-0 Exporter
